Your browser doesn't support javascript.
loading
Combined Nurr1 and Foxa2 roles in the therapy of Parkinson's disease.
Oh, Sang-Min; Chang, Mi-Yoon; Song, Jae-Jin; Rhee, Yong-Hee; Joe, Eun-Hye; Lee, Hyun-Seob; Yi, Sang-Hoon; Lee, Sang-Hun.
Afiliação
  • Oh SM; Department of Biochemistry and Molecular Biology, College of Medicine, Hanyang University, Seoul, Korea Hanyang Biomedical Research Institute, Hanyang University, Seoul, Korea Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, Korea.
  • Chang MY; Hanyang Biomedical Research Institute, Hanyang University, Seoul, Korea.
  • Song JJ; Department of Biochemistry and Molecular Biology, College of Medicine, Hanyang University, Seoul, Korea Hanyang Biomedical Research Institute, Hanyang University, Seoul, Korea Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, Korea.
  • Rhee YH; Department of Biochemistry and Molecular Biology, College of Medicine, Hanyang University, Seoul, Korea Hanyang Biomedical Research Institute, Hanyang University, Seoul, Korea Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, Korea.
  • Joe EH; Department of Phamacology, Ajou University School of Medicine, Suwon, Korea.
  • Lee HS; Department of Applied Bioscience, College of Life Science, CHA University, Seoul, Korea.
  • Yi SH; Hanyang Biomedical Research Institute, Hanyang University, Seoul, Korea sanghooni@hanmail.net leesh@hanyang.ac.kr.
  • Lee SH; Department of Biochemistry and Molecular Biology, College of Medicine, Hanyang University, Seoul, Korea Hanyang Biomedical Research Institute, Hanyang University, Seoul, Korea Graduate School of Biomedical Science and Engineering, Hanyang University, Seoul, Korea sanghooni@hanmail.net leesh@hanyang.
EMBO Mol Med ; 7(5): 510-25, 2015 May.
Article em En | MEDLINE | ID: mdl-25759364
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Mesencéfalo / Terapia Genética / Fator 3-beta Nuclear de Hepatócito / Membro 2 do Grupo A da Subfamília 4 de Receptores Nucleares / Neurônios Dopaminérgicos Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Mesencéfalo / Terapia Genética / Fator 3-beta Nuclear de Hepatócito / Membro 2 do Grupo A da Subfamília 4 de Receptores Nucleares / Neurônios Dopaminérgicos Idioma: En Ano de publicação: 2015 Tipo de documento: Article